Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

June 19, 2018

Study Completion Date

June 19, 2018

Conditions
Visual Acuity, Slit Lamp Biomicroscopy (Corneal Staining Assessment)
Interventions
DEVICE

Opti-Free : RevitaLens / Clear Care : RevitaLens

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

Opti-Free : RevitaLens / RevitaLens : Clear Care

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

Clear Care : RevitaLens/ Opti-Free : RevitaLens

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

Clear Care : RevitaLens / RevitaLens : Opti-Free

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

RevitaLens : Clear Care/ Opti-Free : RevitaLens

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

RevitaLens : Clear Care / RevitaLens : Opti-Free

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

RevitaLens : Opti-Free / Clear Care : RevitaLens

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

DEVICE

RevitaLens : Opit-Free / RevitaLens : Clear Care

Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Trial Locations (5)

32205

Vue Optical Boutique, Jacksonville

43210

The Ohio State University, Columbus

77240

University of Houston College of Optometry, Houston

92807

Southern California College of Optometry, Anaheim

94720

University of California, Berkeley School of Optometry, Berkeley

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT03466060 - Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types | Biotech Hunter | Biotech Hunter